雅虎香港 搜尋

搜尋結果

  1. 2024年10月14日 · The updated efficacy analysis of the phase III MARIPOSA trial continues to favour amivantamab plus lazertinib over osimertinib for first-line (1L) treatment of patients with EGFR-mutant (EGFRm) advanced non-small cell lung cancer (NSCLC).

  2. 2024年10月20日 · MIMS Gastroenterology Singapore brings you the latest medical news and articles on gastroenterology, with info on clinical trials, research, case studies and conference reports on GERD, dyspepsia, acid reflux, heartburn, nausea etc.

  3. 2024年10月23日 · MIMS Neurology Thailand brings you the medical news and articles on neurology with info on clinical trials, research, conferences on dementia, vertigo, migraine, cerebral palsy, epilepsy, multiple sclerosis, Parkinson's disease etc.

  4. 2024年10月15日 · Individuals with resectable stage IA to IIIB non-small cell lung cancer (NSCLC) who plan to receive minimally invasive lung surgery may benefit from intensity-based personalized music therapy (IBP-MT) suggests the phase II Music of Lung Health II study.